Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder

NeuroImage

Volumn 59, Issue 2, 2012, Pages 1461-1468

  Meunier, David ^a   Ersche, Karen D ^a   Craig, Kevin J ^a   Fornito, Alex ^a   Merlo Pich, Emilio ^b   Fineberg, Naomi A ^c   Shabbir, Shaila S ^d   Robbins, Trevor W ^a   Bullmore, Edward T ^a,b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b GSK   (Italy)

^c QUEEN ELIZABETH II HOSPITAL   (United Kingdom)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Addiction; Compulsivity; Connectivity; FMRI; Obsessive compulsive disorder; Orbitofrontal cortex

Indexed keywords

CENTRAL STIMULANT AGENT;

ADULT; ARTICLE; BRAIN CIRCULATION; BRAIN FUNCTION; BRAIN REGION; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DORSAL MEDIAL PREMOTOR CORTEX; DRUG DEPENDENCE; FEMALE; FREQUENCY MODULATION; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; INFERIOR ORBITOFRONTAL CORTEX; MALE; NERVE CELL NETWORK; NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; SUPERIOR ORBITOFRONTAL CORTEX; SYNAPTIC TRANSMISSION; TIME SERIES ANALYSIS;

ADULT; AMPHETAMINE-RELATED DISORDERS; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; OBSESSIVE-COMPULSIVE DISORDER; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 83055194485     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2011.08.003     Document Type: Article

References (47)

1. Achard S., Bullmore E. Efficiency and cost of economical brain functional networks. Plos Comput. Biol. 2007, 3:174-183.
2. Achard S., Salvador R., Whitcher B., Suckling J., Bullmore E. A resilient, low-frequency, small-world human brain functional network with highly connected association cortical hubs. J. Neurosci. 2006, 26:63-72.
3. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders. Text Revision 2000, American Psychiatric Association, Washington, DC. 4th Edition.
4. Bechara A., Damasio H., Tranel D., Damasio A.R. Deciding advantageously before knowing the advantageous strategy. Science 1997, 275:1293-1295.
5. Bechara A., Damasio H., Damasio A.R. Emotion, decision-making and the orbitofrontal cortex. Cereb. Cortex 2000, 10:295-307.
6. Beck A.T., Steer R.A., Brown G.K. Manual for Beck Depression Inventory-II 1996, Psychological Corporation, San Antonio, TX.
7. Belin D., Mar A.C., Dalley J.W., Robbins T.W., Everitt B.J. High impulsivity predicts the switch to compulsive cocaine-taking. Science 2008, 320:1352-1355.
8. Bonson K.R., Grant S.J., Contoreggi C.S., Links J.M., Metcalfe J., Weyl H.L., Kurian V., Ernst M., London E.D. Neural systems and cue-induced cocaine craving. Neuropsychopharmacology 2002, 26:376-386.
9. Buckholtz J.W., Treadway M.T., Cowan R.L., Woodward N.D., Li R., Ansari M.S., Baldwin R.M., Schwartzman A.N., Shelby E.S., Smith C.E., Kessler R.M., Zald D.H. Dopaminergic network differences in human impulsivity. Science 2010, 329:532.
10. Chamberlain S.R., Fineberg N.A., Blackwell A.D., Robbins T.W., Sahakian B.J. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am. J. Psychiatry 2006, 163:1282-1284.
11. Chamberlain S.R., Menzies L., Hampshire A., Suckling J., Fineberg N.A., del Campo N., Aitken M., Craig K., Owen A.M., Bullmore E.T., Robbins T.W., Sahakian B.J. Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives. Science 2008, 321:421-422.
12. Dalley J.W., Fryer T.D., Brichard L., Robinson E.S.J., Theobald D.E.H., Laane K., Pena Y., Murphy E.R., Shah Y., Probst K., Abakumova I., Aigbirhio F.I., Richards H.K., Hong Y., Baron J.C., Everitt B.J., Robbins T.W. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007, 315:1267-1270.
13. Duran F.L.D., Hoexter M.Q., Valentejr A.A., Miguel E.C., Busatto G.F. Association between symptom severity and internal capsule volume in obsessive-compulsive disorder. Neurosci. Lett. 2009, 452:68-71.
14. Elliott R., Friston K.J., Dolan R.J. Dissociable neural responses in human reward systems. J. Neurosci. 2000, 20:6159-6165.
15. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005, 8:1481-1489.
16. Figee, M., Vink, M., de Geus, F., Vulink, N., Veltman, D.J., Westenberg, H., Denys, D., 2011. Dysfunctional Reward Circuitry in Obsessive-Compulsive Disorder. Biol. Psychiatry 69(9), 867-874.
17. Fillmore M.T., Rush C.R. Impaired inhibitory control of behavior in chronic cocaine users. Drug Alcohol Depend. 2002, 66:265-273.
18. Fineberg N.A., Potenza M.N., Chamberlain S.R., Berlin H.A., Menzies L., Bechara A., Sahakian B.J., Robbins T.W., Bullmore E.T., Hollander E. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology 2010, 35:591-604.
19. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders. Research Version, Non-patient Edition. (SCID-I/NP) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
20. Franken I.H.A., Hendriks V.M., Van den Brink W. Initial validation of two opiate craving questionnaires: the obsessive compulsive drug use scale and the desires for drug questionnaire. Addict. Behav. 2002, 27:675-685.
21. Franklin T.R., Acton P.D., Maldjian J.A., Gray J.D., Croft J.R., Dackis C.A., O'Brien C.P., Childress A.R. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol. Psychiatry 2002, 51:134-142.
22. Goodman W.K., Price L.H., Rasmussen S.A., Mazure C., Fleischmann R.L., Hill C.L., Heninger G.R., Charney D.S. The Yale-Brown obsessive compulsive scale. 1. Development, use, and reliability. Arch. Gen. Psychiatry 1989, 46:1006-1011.
23. Harrison B.J., Soriano-Mas C., Pujol J., Ortiz H., Lopez-Sola M., Hernandez-Ribas R., Deus J., Alonso P., Yucel M., Pantelis C., Menchon J.M., Cardoner N. Altered corticostriatal functional connectivity in obsessive-compulsive disorder. Arch. Gen. Psychiatry 2009, 66:1189-1200.
24. Koski L., Wohlschlager A., Bekkering H., Woods R.P., Dubeau M.C., Mazziotta J.C., Iacoboni M. Modulation of motor and premotor activity during imitation of target-directed actions. Cereb. Cortex 2002, 12:847-855.
25. Kringelbach M.L., Rolls E.T. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog. Neurobiol. 2004, 72:341-372.
26. Lee B., London E.D., Poldrack R.A., Farahi J., Nacca A., Monterosso J.R., Mumford J.A., Bokarius A.V., Dahlbom M., Mukherjee J., Bilder R.M., Brody A.L., Mandelkern M.A. Striatal dopamine D2/D3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J. Neurosci. 2009, 29:14734-14740.
27. Mancebo M.C., Grant J.E., Pinto A., Eisen J.L., Rasmussen S.A. Substance use disorders in an obsessive compulsive disorder clinical sample. J. Anxiety Disord. 2009, 23:429-435.
28. Matochik J.A., London E.D., Eldreth D.A., Cadet J.L., Bolla K.I. Frontal cortical tissue composition in abstinent cocaine abusers: a magnetic resonance imaging study. NeuroImage 2003, 19:1095-1102.
29. Menzies L., Achard S., Chamberlain S.R., Fineberg N.A., Chen C.-H., del Campo N., Sahakian B.J., Robbins T.W., Bullmore E.T. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007, 13. e-pub ahead of print, September.
30. Menzies L., Williams G.B., Chamberlain S.R., Ooi C., Fineberg N., Suckling J., Sahakian B.J., Robbins T.W., Bullmore E.T. White matter abnormalities in patients with obsessive-compulsive disorder and their first-degree relatives. Am. J. Psychiatry 2008, 165:1308-1315.
31. Menzies L., Chamberlain S.R., Laird A.R., Thelen S.M., Sahakian B.J., Bullmore E.T. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci. Biobehav. Rev. 2008, 32:525-549.
32. Merikangas K.R., Stolar M., Stevens D.E., Goulet J., Preisig M.A., Fenton B., Zhang H.P., O'Malley S.S., Rounsaville B.J. Familial transmission of substance use disorders. Arch. Gen. Psychiatry 1998, 55:973-979.
33. Moeller F.G., Barratt E.S., Dougherty D.M., Schmitz J.M., Swann A.C. Psychiatric aspects of impulsivity. Am. J. Psychiatry 2001, 158:1783-1793.
34. Monterosso J.R., Aron A.R., Cordova X., Xu J., London E.D. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug Alcohol Depend. 2005, 79:273-277.
35. Montgomery S.A., Asberg M. New depression scale designed to be sensitive to change. Br. J. Psychiatry 1979, 134:382-389.
36. Nestadt G., Samuels J., Riddle M., Bienvenu O.J., Liang K.Y., LaBuda M., Walkup J., Grados M., Hoehn-Saric R. A family study of obsessive-compulsive disorder. Arch. Gen. Psychiatry 2000, 57:358-363.
37. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. J. Clin. Psychol. 1995, 51:768-774.
38. Potenza M.N., Taylor J.R. Found in translation: understanding impulsivity and related constructs through integrative preclinical and clinical research. Biol. Psychiatry 2009, 66:714-716.
39. Rubia K., Smith A.B., Brammer M.J., Taylor E. Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection. NeuroImage 2003, 20:351-358.
40. Schoenbaum G., Shaham Y. The role of orbitofrontal cortex in drug addiction: a review of preclinical studies. Biol. Psychiatry 2008, 63:256-262.
41. Suckling J., Davis M.H., Ooi O., Wink A.M., Fadili J., Salvador R., Welchew D., Sendur L., Maxim V., Bullmore E.T. Permutation testing of orthogonal factorial effects in a language-processing experiment using fMRI. Hum. Brain Mapp. 2006, 27:425-433.
42. Szeszko P.R., Ardekani B.A., Ashtari M., Malhotra A.K., Robinson D.G., Bilder R.M., Lim K.O. White matter abnormalities in obsessive-compulsive disorder - a diffusion tensor imaging study. Arch. Gen. Psychiatry 2005, 62:782-790.
43. Volkow N.D., Fowler J.S. Addiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex. Cereb. Cortex 2000, 10:318-325.
44. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.J., Dewey S.L., Wolf A.P. Decreased dopamine-D(2) receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993, 14:169-177.
45. Volkow N.D., Chang L., Wang G.J., Fowler J.S., Ding Y.S., Sedler M., Logan J., Franceschi D., Gatley J., Hitzemann R., Gifford A., Wong C., Pappas N. Low level of brain dopamine D-2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 2001, 158:2015-2021.
46. Wallis J.D. Orbitofrontal cortex and its contribution to decision-making. Annu. Rev. Neurosci. 2007, 30.
47. Weissman D.H., Gopalakrishnan A., Hazlett C.J., Woldorff M.G. Dorsal anterior cingulate cortex resolves conflict from distracting stimuli by boosting attention toward relevant events. Cereb. Cortex 2005, 15:229-237.